1. Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017. (20th March 2017) Authors: Ženka, J.; Caisová, V.; Uher, O.; Nedbalová, P.; Kvardová, K.; Masáková, K.; Krejčová, G.; Paďouková, L.; Jochmanová, I.; Wolf, K. I.; Chmelař, J.; Kopecký, J.; Loumagne, L.; Mestadier, J.; D'agostino, S.; Rohaut, A.; Ruffin, Y.; Croize, V.; Lemaître, O.; Sidhu, S. S. Journal: Journal for immunotherapy of cancer Issue: Volume 5(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P475: CONTROL LEUKEMIA BY INDUCING ANTI-CANCER IMMUNE REACTIVITY IN VIVO? POTENTIAL OF A DC-TRIGGERED MECHANISM. (23rd June 2022) Authors: Filippini Velazquez, G.; Amberger, D.; Klauer, L.; Rackel, E.; Atzler, M.; Ugur, S.; Plett, C.; Rabe, A.; Kugler, C.; Rank, A.; Inngjerdingen, M.; Baudrexler, T.; Eiz-Vesper, B.; Schmid, C.; Schmetzer, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells. (March 2018) Authors: Schmid, C.; Atzler, M.; Rank, A.; Inngjerdingen, M.; Rabe, A.; Deen, D.; Wang, R.; Eiz-Vesper, B.; Schmetzer, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Standard normoxic versus physiological hypoxic culture of AML patients' (pts) whole blood (WB) samples with immune modulatory kits yields comparable proportions of dendritic cells and functional results. (March 2018) Authors: Doraneh gard, F.; Amberger, D.; Weinmann, M.; Boeck, C.; Gunsilius, C.; Kugler, C.; Werner, J.; Kraemer, D.; Rank, A.; Schmid, C.; Schmetzer, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers. (March 2019) Authors: Atzler, M.; Rank, A.; Inngjerdingen, M.; Rabe, A.; Deen, D.; Wang, R.; Eiz-Vesper, B.; Schmid, C.; Schmetzer, H. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗